Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) was the recipient of a significant growth in short interest in January. As of January 15th, there was short interest totalling 43,270,000 shares, a growth of 18.8% from the December 31st total of 36,410,000 shares. Approximately 21.7% of the company’s stock are sold short. Based on an […]
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report)’s share price shot up 5.3% during mid-day trading on Monday . The stock traded as high as $7.99 and last traded at $7.99. 2,244,142 shares changed hands during trading, a decline of 65% from the average session volume of 6,496,278 shares. The stock had previously closed at […]
StockNews.com upgraded shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) to a sell rating in a report published on Wednesday morning. Several other equities analysts have also weighed in on the stock. HC Wainwright decreased their target price on shares of Iovance Biotherapeutics from $38.00 to $28.00 and set a buy rating on the stock […]
Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) have earned a consensus rating of “Buy” from the eleven brokerages that are currently covering the company, Marketbeat.com reports. Eleven equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokerages that have covered the stock in the […]